1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ILK CTRPv2 pan-cancer AAC -0.14 6e-05
mRNA TCEANC2 CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA SPHK2 CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA MMP11 CTRPv2 pan-cancer AAC 0.13 6e-05
mRNA EDEM1 CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA INA CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA CYTH4 CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA MAPK8IP1 CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA CNTROB CTRPv2 pan-cancer AAC 0.13 6e-05
mRNA ZNF362 CTRPv2 pan-cancer AAC 0.13 6e-05
Download CSV